Metformin Bluefish

Metformin, the active ingredient in Metformin Bluefish, is a biguanide presented as an oral dosage form for oral use. It is used to improve blood glucose control in adults with type 2 diabetes and is also employed off‑label for polycystic ovary syndrome.

GNH USA supplies Metformin Bluefish as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides regulatory‑approved batches to global markets.

Metformin is indicated for conditions related to impaired glucose metabolism and associated endocrine disorders.

- Type 2 diabetes mellitus: lowers fasting and post‑prandial blood glucose levels. - Polycystic ovary syndrome (off‑label): improves insulin resistance and may restore ovulatory cycles. - Prediabetes: helps delay progression to overt diabetes by improving glycaemic control.

Metformin may cause a range of adverse reactions, which are grouped by frequency and severity.

Common Side Effects: - Nausea - Diarrhoea - Abdominal discomfort - Metallic taste

Serious or Rare Side Effects: - Lactic acidosis - Severe allergic reaction (e.g., skin rash, angio‑edema) - Hepatotoxicity

When prescribing Metformin, clinicians should consider several safety precautions to minimize risk.

- Renal function monitoring: assess creatinine clearance before initiation and periodically thereafter. - Hepatic status assessment: avoid use in patients with significant liver disease. - Vitamin B12 surveillance: long‑term therapy may reduce B12 levels; monitor periodically. - Cardiovascular caution: use with care in acute heart failure or unstable cardiac conditions. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Metformin can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate acute renal failure, increasing lactic acidosis risk. - Alcohol: potentiates lactic acidosis, especially with chronic intake. - Cimetidine: can raise plasma metformin concentrations.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycaemia symptoms. - Diuretics: can impair renal clearance of metformin. - ACE inhibitors/ARBs: monitor renal function and electrolytes when combined.